Eli Lilly to Acquire AtaiBeckley for $6.75 Per Share Plus CVR
Eli Lilly has proposed acquiring AtaiBeckley for $6.75 per share in cash plus up to $2.50 per share in contingent value rights tied to BPL-003 and VLS-01 milestones.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.